Drug recall
GABAPENTIN *** Capsules *** 300 mg *** Rx Only *** 2000 Capsules (Yellow/White) *** IVAX Pharmaceuticals…
FDA recall event 35993 · Class II · IVAX Pharmaceuticals
Key facts
| Event ID | 35993 |
|---|---|
| Recall numbers | D-331-6 |
| Recalling firm | IVAX Pharmaceuticals |
| Product type | Drugs |
| Products | GABAPENTIN *** Capsules *** 300 mg *** Rx Only *** 2000 Capsules (Yellow/White) *** IVAX Pharmaceuticals, Inc.****** NDC 0172-4382-88 *** |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | The Active Pharmaceutical Ingredient (API) do not meet specifications. |
| Initiation date | Jun 20, 2006 |
| Termination date | May 27, 2011 |
| City | Miami |
| State | FL |
| Country | United States |
| FEI number | 3002047518 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports